Liposomal Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
PHASE1CompletedINTERVENTIONAL
Timeline
Start Date
Not specified
Primary Completion Date
February 28, 2006
Conditions
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Interventions
DRUG
carboplatin
DRUG
pegylated liposomal doxorubicin hydrochloride
All Listed Sponsors
collaborator
National Cancer Institute (NCI)
NIH
lead
Gynecologic Oncology Group
NETWORK
NCT00006235 - Liposomal Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | Biotech Hunter | Biotech Hunter